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Nicotinic acetylcholine receptors (nAChRs) potently regulate dopamine (DA) release in the
striatum and alter cocaine’s ability to reinforce behaviors. Since cocaine is a weak nAChR
inhibitor, we hypothesized that cocaine may alter DA release by inhibiting the nAChRs
in DA terminals in the striatum and thus contribute to cocaine’s reinforcing properties
primarily associated with the inhibition of DA transporters. We found that biologically
relevant concentrations of cocaine can mildly inhibit nAChR-mediated currents in midbrain
DA neurons and consequently alter DA release in the dorsal and ventral striatum. At
very high concentrations, cocaine also inhibits voltage-gated Na channels in DA neurons.
Furthermore, our results show that partial inhibition of nAChRs by cocaine reduces evoked
DA release. This diminution of DA release via nAChR inhibition more strongly influences
release evoked at low or tonic stimulation frequencies than at higher (phasic) stimulation
frequencies, particularly in the dorsolateral striatum. This cocaine-induced shift favoring
phasic DA release may contribute to the enhanced saliency and motivational value of
cocaine-associated memories and behaviors.
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INTRODUCTION
Midbrain dopamine (DA) projections to the striatum comprise
an important neuronal system mediating the initiation of drug
addiction (Bonci et al., 2003; Wise, 2004; Hyman et al., 2006).
The most well known action of the addictive drug cocaine is
its inhibition of monoamine transporters, such as the DA trans-
porter (DAT), with an affinity of about 500 nM (Ritz et al., 1987;
Pristupa et al., 1994; Jones et al., 1995). In the brains of abusers,
however, cocaine often reaches concentrations of 5–10μM for
considerable durations, and higher concentrations are achieved
for shorter times depending on the route of administration and
other factors (Mittleman and Wetli, 1984; Evans et al., 1996;
Ward et al., 1997; Fowler et al., 1998). In addition, cocaine
inhibits α4β2-containing (α4β2∗) nicotinic acetylcholine recep-
tors (nAChRs) with an IC50 in the range of 5–15μM (Damaj
et al., 1999; Francis et al., 2000). This inhibition may be signifi-
cant because α4β2∗ nAChRs (often in combination with α6) are
highly expressed inDA neuron somata and terminals (Mansvelder
and McGehee, 2000; Jones et al., 2001; Champtiaux et al., 2003;
Wooltorton et al., 2003; Quik and McIntosh, 2006; Zanetti et al.,
2006), and nAChRs have been shown to regulate the frequency
dependence of DA release (Zhou et al., 2001; Rice and Cragg,
2004; Zhang and Sulzer, 2004; Exley and Cragg, 2008; Zhang
et al., 2009a). Intertwined with the DA neurons and their axons,
cholinergic neurons in the midbrain and brainstem project to the
substantia nigra and ventral tegmental area (VTA) (Woolf and
Butcher, 1986; Gould et al., 1989; Oakman et al., 1995), while
cholinergic interneurons in the striatum innervate locally (Woolf
and Butcher, 1981; Zhou et al., 2001; Nelson et al., 2014), pro-
viding the endogenous neurotransmitter ACh to the nAChRs in
these DA areas.
In the striatum, DA release is normally dependent on both
afferent spikes along DA fibers and nAChR activity at axonal
and presynaptic locations (Zhou et al., 2001; Grady et al., 2002;
Salminen et al., 2004; Zhang et al., 2009a). The nAChRs nor-
mally increase the initial DA release probability, and regulate
the frequency dependence of DA release (Rice and Cragg, 2004;
Zhang and Sulzer, 2004; Exley and Cragg, 2008; Zhang et al.,
2009a). Cholinergic interneuron activity may directly facilitate
DA release fromDA axon terminals in the dorsal and ventral stria-
tum (Cachope et al., 2012; Threlfell et al., 2012). Inactivation of
nAChRs on the DA fibers decreases the DA release probability
and increases the phasic to tonic DA ratio (Rice and Cragg, 2004;
Exley and Cragg, 2008; Zhang et al., 2009a). Based on those pub-
lished findings, we hypothesized that cocaine acts via nAChRs to
regulate DA signals beyond the expected inhibition of DATs.
MATERIALS AND METHODS
MICE
Male and female C57BL/6J mice from The Jackson Laboratory
(Bar Harbor, Maine), β2-subunit knockout (KO) mice (Xu et al.,
1999), DAT knockin mice having DATs that are insensitive to
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cocaine (Chen et al., 2006), and their wild-type (W-T) littermates
were used in our present study. The mutant mice were generated,
maintained, euthanized and genotyped according to established
procedures (Xu et al., 1999; Chen et al., 2006) and in accordance
with national and institutional guidelines. Experiments on the
mutant mice and their W-T littermates were performed double
blind.
FAST-SCAN CYCLIC VOLTAMMETRY (FCV) IN STRIATAL BRAIN SLICES
For these studies, horizontal brain slices (Figure 1) containing
the striatum (400μm in thickness) from mice 1–3 months old
were cut on a Leica VT1000 or Leica VT1200s vibratome (Zhang
et al., 2009a). Anesthesia, handling, and experimental proce-
dures followed our established techniques at 30◦C (Zhou et al.,
2001).
FCV was performed with home-made carbon-fiber electrodes
constructed from P55S carbon fibers of 10μm diameter (Amoco
Polymers, Greenville, SC). Axopatch 200B amplifier, pClamp 9
software, and Digidata 1320A interface (Axon Instruments) were
used to acquire and analyze data. The holding potential was 0mV
between scans. Scans of 20ms duration were applied at 10 or
20Hz. The scans were from 0mV to −400 to 1000 to −400 to 0
at a rate of 300mV/ms and were sampled at 50 kHz. The peaks
of the voltammograms were plotted over time and converted
FIGURE 1 | Arrangement for electrical stimulation and FCV recording
in striatal brain slices. The striatum is easily identified by its anatomical
location and the distinct fiber bundles in horizontal brain slices. Local
electrical stimulation in the striatum was delivered using a bipolar tungsten
electrode. The two tips of the stimulating electrode were ∼150μm away
from each other and from the carbon fiber microelectrode (CFM) tip. GP,
globus pallidus; IC, internal capsule; SP, septum.
to concentrations by post-experiment calibration with 0.1–5μM
DA standards.
Local electrical stimulation in the striatum was delivered
using a bipolar tungsten electrode (Figure 1). The two tips of
the stimulating electrode were ∼150μm away from each other.
The tip of the carbon-fiber recording electrode was 100–200μm
away from the two tips of the stimulating electrode. The stim-
uli were relatively weak (0.1–0.2mA for 0.1ms) helping to keep
the recording stable and minimize local interactions. The inter-
val between single pulses was usually 100 s. Additional types of
stimulation were used: tonic stimulation of 4 pulses at 4Hz, pha-
sic stimulation of 4 pulses at 20Hz, and paired pulses separated
by 50ms. Cocaine was bath-applied for 10min and then was
washed out.
PATCH CLAMP RECORDING OF MIDBRAIN DA NEURONS
Coronal or horizontal midbrain slices, 200–300μm in thickness
and containing the substantia nigra pars compacta (SNc) and/or
the VTA, were prepared from 15 to 30 day old mice according
to established procedures (Pidoplichko et al., 1997). Visualized
recordings weremade at 30◦Cusing an Axopatch 200 and pClamp
data acquisition and analysis software.
nAChR-mediated currents in putative DA neurons were
induced by pressure application of 1mMACh using a Picospritzer
(General Valve) attached to a puffer pipette (Pidoplichko and
Dani, 2005). The puffer was ∼30μm from the neuron while
ACh was applied (25 psi for 100ms). Then, the puffer was
retracted 100–200μm between ACh applications by a computer-
controlled manipulator to prevent leak-induced desensitization
(Wooltorton et al., 2003; Pidoplichko and Dani, 2005). For this
experiment, the brain slices were bathed in a normal extracellular
solution containing (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH2PO4,
25 NaHCO3, 2.5 CaCl2, 1.3 MgCl2, and 10 D-glucose that
were continuously bubbled with 95% O2 and 5% CO2. The
intracellular solution contained (in mM): 135 KCl, 0.5 EGTA,
10 HEPES, 2 Mg-ATP, 0.2 Na-GTP, and 4 Na2-phosphocreatine.
pH 7.25, 280–290mOsm. To record the fast voltage-activated
sodium current (INa), the presumed nigral DA neuron (based
on its slow firing rate at ∼1Hz in cell-attached mode, see Ding
et al., 2011) was held at −90mV and then stepped to 0mV for
10ms. For this experiment, 2.5mM CaCl2 were substituted by
2.5mM MgCl2, and extracellular NaCl was reduced to 25mM,
20mM TEA and 5mM 4-AP were used to inhibit K currents;
the following Cs-based intracellular solution was also used that
contained (in mM): 135 CsCl, 0.5 EGTA, 10 HEPES, 2 Mg-ATP,
0.2 Na-GTP, 4 Na2-phosphocreatine with pH was adjusted to 7.25
with CsOH.
Neurobiotin (0.2%) was included in the recording electrode
and allowed to diffuse into the cell using approaches described
previously (Pidoplichko et al., 1997). After recording, the brain
slices were fixed in 4% paraformaldehyde in 0.1M phosphate
buffer. Double immunostaining was performed according to
established procedures (Pidoplichko et al., 1997; Neuhoff et al.,
2002). Tyrosine hydroxylase (TH, a marker for midbrain DA neu-
rons) was detected with a sheep anti-TH primary antibody and
rhodamine red-X-tagged donkey anti-sheep secondary antibod-
ies (Figure 2A2). Neurobiotin was detected with red Cy2-tagged
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FIGURE 2 | Cocaine inhibits nicotinic currents in midbrain DA neurons
from W-T mice. (A,A1) The membrane properties of presumed DA
neurons from the lateral VTA or SNc were typical of DA neurons with a
strong Ih sag (arrow). Injected current was 40 pA/step. Spikes were
partially truncated for display. (A,A2) These midbrain DA neurons were
backfilled with neurobiotin (green) and labeled for TH (red). The
co-incidence of neurobiotin and TH is shown as yellow (Overlay),
confirming the DA neuron identification. (B,B1) Three traces show nicotinic
currents induced in a DA neuron by pressure application of ACh (1mM,
100ms pulse) under control conditions (left), with 10μM cocaine present
(middle), or with 25 nM DHβE present (right), which was applied after
recovering from cocaine inhibition. The recordings were made in the
presence of 1μM atropine at a holding potential of −70mV. (B,B2)
Examples showing DHβE inhibits nicotinic currents in DA neurons. (B,B3)
The dose-response relationships for inhibition of nAChR currents. The
curves through the data were produced with IC50 = 19.8μM and Hill
coefficient = 1.3 for cocaine, and IC50 = 82nM and Hill coefficient = 1.1
for DHβE with n = 3–9 per data point.
strepavidin antibody (Figure 2A2). Sections were examined on a
Bio-Rad confocal laser-scanning microscope.
CHEMICALS
All chemicals including cocaine-HCl were purchased from Sigma
Aldrich (St. Louis, MO) or Tocris (Ellisville, MO). Cocaine was
also obtained from the NIH/NIDA’s Drug Supply Program.
STATISTICS
The data are displayed as the mean and the standard error.
Paired t-test was used to compare measurements before and dur-
ing various pharmacological treatments. P < 0.05 was considered
statistically significant. When applicable, the averaged data points
in dose-response plots were fitted with the Hill equation to esti-
mate IC50 and Hill coefficient. These and other computations
were performed using the Origin analysis and plotting program
(Northampton, MA).
RESULTS
COCAINE DIRECTLY INHIBITS nAChRs ON DA NEURONS
Because cocaine inhibits cloned neuronal nAChRs in heterol-
ogous expression systems (Damaj et al., 1999; Francis et al.,
2000), we tested whether cocaine inhibits nAChRs expressed on
DA neurons of the SNc and the lateral VTA (Picciotto et al.,
1995; Pidoplichko et al., 1997; Mansvelder and McGehee, 2000;
Wooltorton et al., 2003). DA neurons were initially identified
by their characteristic membrane properties. The presumed DA
neurons within the lateral midbrain fired spontaneously (2.1 ±
0.3Hz, n = 9), displayed prominent Ih currents (Figure 2A1) and
had relatively long spike durations (2.7 ± 0.3ms at the base,
n = 9). These membrane properties were consistent with com-
monly recognized DA neuron properties from this area (Neuhoff
et al., 2002; Ford et al., 2006; Beckstead andWilliams, 2007; Zhang
et al., 2010; Ding et al., 2011; Li et al., 2011). These electro-
physiologically identified DA neurons were further confirmed by
back filling with neurobiotin and subsequently staining for TH
(Figure 2A2).
In these DA neurons, pressure application of ACh (100ms
pulse of 1mM ACh, 1μM atropine was always present) induced
currents (Figure 2B1, left trace) that have previously been char-
acterized as predominantly β2∗ nAChR currents, and these cur-
rents can be inhibited by 1μM dihydro-β-erythroidine (DHβE)
(Alkondon and Albuquerque, 1993; Wooltorton et al., 2003). In
the presence of a cocktail of antagonists to inhibit DA transporters
(2μM GBR12909), D2-like autoreceptors (1μM sulpiride), and
muscarinic receptors (1μM atropine), bath application of 10μM
cocaine inhibited the nAChR currents (Figure 2B1, middle trace).
This concentration (10μM cocaine) is within the range achieved
by cocaine abusers and by animals during self-administration
experiments (Mittleman andWetli, 1984; Evans et al., 1996; Ward
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et al., 1997; Fowler et al., 1998; Nicola and Deadwyler, 2000).
The dose-response curve for cocaine inhibition of nAChR cur-
rents from SNc DA neurons had an apparent IC50 of 19.8 ±
1.5μM and Hill coefficient of 1.3 ± 0.3 (n = 3–9, Figure 2B3),
and the results were statistically the same for nAChRs in the VTA
(IC50 of 19.5 ± 1.8μM, Hill coefficient of 1.3 ± 0.2). To indicate
the effectiveness of cocaine inhibition, the nicotinic antagonist,
DHβE, was characterized with an apparent IC50 of 82.3 ± 4.3 nM
and Hill coefficient of 1.1 ± 0.4 (n = 3–7, Figures 2B2,B3).
These results suggest that cocaine directly inhibits nAChRs on DA
neurons and, thus, acts as a weak nicotinic antagonist. Because
the predominant β2-containing nAChRs on the cell body and
axon terminals appear to be qualitatively similar (Champtiaux
et al., 2003; Salminen et al., 2004; Quik and McIntosh, 2006),
cocaine’s nicotinic antagonism likely also occurs at DA axon ter-
minals. Since the selective DAT inhibitor GBR12909 was also
used in this study, we tested the potential effect of GBR12909
on nAChR-mediated currents as a separate control experiment.
We found that GBR12909 (5μM, the highest concentration we
used) did not inhibit nAChR currents in 5 DA neurons tested.
Since nAChRs facilitate DA release (Zhou et al., 2001; Rice and
Cragg, 2004; Zhang and Sulzer, 2004; Zhang et al., 2009a; Threlfell
et al., 2012), our result on cocaine inhibition of nAChRs leads
to this question: can cocaine also affect DA release at DA axon
terminals?
COCAINE INHIBITS DA RELEASE EVOKED BY A SINGLE PULSE
Cocaine is known to inhibit DA reuptake with a Ki of about
0.5μM (Ritz et al., 1987). This effect is also well documented in
the FCV literature (e.g., Jones et al., 1995) and readily observed
under our current experimental conditions (see Figures 6A1,B1),
but is not the focus of our present study. Our focus here is to
determine if cocaine, at concentrations above what is needed to
inhibit DATs, can affect DA release, because at the relatively high
concentrations attained by abusers, the previous section suggests
that cocaine inhibits nAChRs onDAfibers and terminals that nor-
mally regulate DA release. Therefore, we reasoned that cocaine
at different concentrations alters the DA signal in qualitatively
different manners via inhibition of DATs vs. nAChRs.
To examine cocaine’s nAChR-mediated influence over DA sig-
nals, we electrically stimulated DA release and monitored the DA
concentration using FCV in brain slices containing the striatum.
The DA signal was evoked every 100 s in the dorsolateral striatum
and was commonly stable for >2 h during our recordings (Zhou
et al., 2001; Zhang et al., 2009a). Confounding mechanisms were
minimized in all of the experiments by using pharmacological
treatments. Sulpiride (1μM) was used to inhibit DA autoin-
hibition by D2-like receptors. SKF83566 (1μM) was used to
inhibit D1-like receptors to prevent changes in cholinergic tone
that affects DA release (Zhou et al., 2001). GBR12909 (1–5μM),
which has an IC50 ∼10 nM vs. cocaine’s IC50 ∼0.5μM, was used
to minimize DA reuptake by DATs. Therefore, pretreatment with
GBR12909 (1–5μM) occludes cocaine’s effect on DA reuptake by
DATs.
Under these pharmacological conditions (with DATs inhib-
ited), cocaine at concentrations that would normally inhibit DATs
(0.1–1μM) did not enhance the amplitude or duration of the
already prolonged DA signal, as is indicated in the dose-response
curve (Figure 3B, filled symbols). In other words, cocaine no
longer enhanced the DA signal because DATs were already inhib-
ited by GBR12909. However, at the same concentrations that
inhibited nAChRs (Figure 2B1), cocaine (10μM) and DHβE
(25 nM) substantially inhibited DA release evoked by a single-
pulse (1 p) stimulus (Figures 3A,B). Cocaine inhibited the DA
signal with an estimated IC50 of 4.3 ± 0.3μM (n = 8) and a
Hill coefficient of 3 (Figure 3B, filled symbols). The high Hill
coefficient is indicative of a cocaine effect on Ca2+-triggered
vesicular DA release, which has high cooperativity (Lou et al.,
2005). Under the same pharmacological conditions, DA release
evoked by 1 p also was inhibited by the nicotinic antagonist DHβE
with an apparent IC50 of 22.3 ± 1.7 nM and Hill coefficient of 3
(Figure 3B, open symbols). The influence of cocaine over the DA
release evoked by 1 p was comparable in the dorsolateral stria-
tum (Figures 3A,B) and in the NAc shell of the ventral striatum
(Figures 3C,D).
To verify that cocaine was not acting via DAT inhibition when
GBR12909 was present in these experiments, we repeated the
experiments using mutant mice possessing DATs that are insen-
sitive to cocaine (Chen et al., 2006) instead of using GBR12909. A
similar effect was seen when cocaine (10μM) was applied while
stimulating DA release in the presence of 1μM sulpiride and
1μM SKF83566 (Figure 4A, dorsolateral striatum; Figure 4B,
NAc shell). The DA release to a 1 p stimulation was inhibited by
cocaine (10μM), and the dose-response relationships for cocaine
inhibition of DA release is shown to the right in Figure 4. These
results verify that cocaine inhibits DA release separately from its
influence over DA reuptake or D2-like receptors.
COCAINE REDUCES DA RELEASE BY INHIBITING nAChRs
The results to this point show that cocaine can decrease DA release
evoked by a 1 p stimulus. Cocaine’s ability to inhibit nAChRs sug-
gests that the mechanism of action is via nAChRs on DA fibers or
terminals. The nAChRs that normally facilitate DA release contain
the β2 subunit (Zhou et al., 2001; Salminen et al., 2004; Zhang
et al., 2009a; Drenan et al., 2010; Exley et al., 2011). In nAChR
β2-subunit KO mice, DA release does not depend on nAChR
activation (Zhou et al., 2001; Zhang et al., 2009a). Therefore, if
cocaine decreases DA release in response to a 1 p stimulus via
nAChR inhibition, then β2-subunit KOmice should not show this
cocaine-mediated effect.
In the dorsolateral striatum of β2-subunit KO mice, 1 p
stimulation evoked nAChR-independent DA release that had an
amplitude 70% smaller than that observed in W-T mice, as has
been shown previously (Zhou et al., 2001). The smaller evoke DA
signals are observable by comparing Figure 3A (left trace com-
pared to the right trace after inhibition of nAChRs) to Figure 5A
(left trace, note the change in scale). In the presence of GBR12909
(1–5μM) to inhibit DATs, cocaine doses ranging from 50 nM
to 5μM did not affect the amplitude or duration of the evoked
DA signal in β2-subunit KO mice (Figure 5B). A concentration
of cocaine (10μM) that caused a 74.9 ± 7.8% decrease in DA
release in W-T mice (Figures 3A,B), produces only 7.6 ± 2.4%
inhibition in nAChR β2 KO mice (Figures 5A,B). In W-T mice,
cocaine reduced DA release with an IC50 of 4.3μM (Figure 5B,
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FIGURE 3 | Cocaine reduces DA release in the striatum from W-T mice.
(A) Cocaine inhibits DA release from the dorsolateral striatum evoked by
single-pulse (1 p) stimulation measured using fast-scan cyclic voltammetry.
The recordings show the prolonged DA signal after DAT inhibition with 5μM
GBR12909 (left trace). DA release was substantially reduced by 10μM
cocaine (middle trace). After recovery from cocaine inhibition, 25 nM DHβE
induced a similar inhibition of the DA signal (right trace). 1μM sulpiride
(D2-like antagonist) and SKF83566 (D1-like antagonist) were used to block
local interactions in the striatum. (B) The dose-response relationships for
inhibition of DA release. The curves through the data were produced with
IC50 = 4.3μM for cocaine and 22 nM for DHβE both with a Hill coefficient
estimated to be 3 (n = 4–8 per data point). Data points with cocaine
concentrations higher than 15μM were not included in the fitting because a
component arising from a local anesthetic effect was also present. (C)
Likewise, cocaine inhibits DA release evoked by 1 p stimulation from the NAc
shell measured using fast-scan cyclic voltammetry in the presence of 5μM
GBR12909, 1μM sulpiride, and 1μM SKF83566. (D) The dose-response
relationship for inhibition of DA release in the NAc shell.
FIGURE 4 | In mutant mice having cocaine-insensitive DATs, DA
release evoked by 1 p stimulation was still inhibited by cocaine
(10μM). (A) In 10μM cocaine (middle trace) the DA signal was
inhibited when compared to the control (left) or after washout of
cocaine (right, wash). The dose-response relationship for cocaine
inhibition (extreme right) was fitted with a curve through the data
having IC50 = 4μM and Hill coefficient = 3.2. (B) Likewise, cocaine
(10μM) inhibits DA release evoked by 1 p stimulation from the NAc
shell. The dose-response relationship for inhibition of DA release in the
NAc shell by cocaine (extreme right) was fitted by a curve with IC50 =
5.2μM and the Hill coefficient = 3.0. The traces were collected in the
presence of 1μM sulpiride, and 1μM SKF83566.
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FIGURE 5 | In β2-subunit KO mice DA release evoked by 1 p stimulation
was resistant to inhibition by cocaine (10μM). (A) All the slices were
bathed in 2μM GBR12909 to block DATs and to remove complications arising
from changes in DA reuptake. The control DA signal (left) evoked by 1 p
stimulation shows a prolonged duration caused by inhibiting DA reuptake. In
10μM cocaine (middle trace) there was slight inhibition of the DA signal. In
40μM cocaine (right trace) there was a much greater inhibition of the DA
signal. 1μM sulpiride and SKF83566 were used to block local DA receptor
influences within the striatum. (B) The dose-response relationship for cocaine
inhibition of DA release in the dorsolateral striatum of β2-nAChR KO mice.
The curve through the data was produced with IC50 = 26μM and the Hill
coefficient = 3 (red curve) (n = 4–6 slices). For comparison, the black curve
from Figure 1 obtained with W-T mice is given to show the substantial
decrease in cocaine-mediated inhibition when β2∗ nAChRs were absent. (C)
Likewise, cocaine (10μM) did not, but cocaine (40μM) did, inhibit DA release
evoked by 1 p stimulation from the NAc shell again in the presence of 2μM
GBR12909, 1μM sulpiride, and 1μM SKF83566. (D) The dose-response
relationships for inhibition of DA release in the NAc shell by cocaine in
β2-subunit KO mice (red curve) (n = 4–5 slices) compared to the W-T mice
(black curve).
smooth black curve), but in nAChR β2 KO mice the IC50 shifts
to 26.4 ± 2.3μM with a Hill coefficient of 3.0 (Figure 5B, red
curve) (n = 4–6 slices for each data points). Comparable results
(that may be similarly interpreted) were also obtained in the NAc
shell (Figures 5C,D) from nAChR β2 KO mice.
For completeness, the whole range of cocaine’s influence
over the 1 p stimulated DA release is shown in the absence of
GBR12909 in W-T mice normally expressing nAChRs in the
dorsolateral striatum (Figure 6A) or the NAc shell (Figure 6C).
At low cocaine concentrations, DATs are inhibited by cocaine,
and the DA peak becomes larger (DAT effect, Figures 6A,A1,C).
At cocaine concentrations above 1μM, the DA peak decreases.
As indicated by the earlier results, cocaine begins to inhibit
nAChRs at this concentration (nAChR effect, Figures 6A,C).
When nAChRs are absent (i.e., nAChR β2 KO mice), cocaine
does not begin to inhibit the DA peak amplitude until ≥20μM
(Figures 6B,B1,D). The overall effect of cocaine acting via
nAChRs is depicted in Figure 6B. The inhibition of the DA
peak by ≥20μM cocaine likely also involves the local anesthetic
effect (Anesthetic effect, Figure 6), arising from cocaine inhibi-
tion of voltage-activated channels (e.g., sodium and/or calcium
channels) and action potentials (O’Leary and Chahine, 2002).
We verified that cocaine inhibited the fast sodium current in
DA neuron somata in a dose-dependent manner (Figures 7A,B)
that likely contributed to the decreased DA release seen at
very high cocaine concentrations (Anesthetic effect, Figure 6).
Because DA release depends of the 4th power of the intraterminal
calcium concentration that arises from the depolarization caused
by voltage-gated ion channels, cocaine’s inhibition of voltage-
gated channels (e.g., INa currents in Figure 7) is magnified when
observing the effect over DA release (Figure 6).
COCAINE REDUCES PAIRED-PULSE DEPRESSION OF DA RELEASE
DEPENDENT ON nAChRs
The results presented above indicate that cocaine acts as a nAChR
antagonist at DA fibers and terminals in the striatum and via
this mechanism reduces DA release evoked by a single pulse or
low frequency stimulation. This reduction in DA release is, of
course, relative to the release that would be seen if cocaine did
not slightly inhibit nAChRs. Inhibition of nAChRs also has been
shown to reduce paired-pulsed depression of DA release (Rice and
Cragg, 2004; Zhang and Sulzer, 2004). Paired-pulse depression
largely depends on the initial neurotransmitter release proba-
bility. The higher the initial release probability, the stronger the
paired-pulse depression (Zucker and Regehr, 2002). Therefore, if
cocaine is inhibiting nAChRs, it should decrease the initial DA
release probability and reduce paired-pulse depression.
To test this idea, we performed paired-pulse experiments
using two stimuli separated by 50ms (i.e., 20Hz). The exper-
iments were conducted in the presence of sulpiride (1μM) to
block autoinhibition by D2-like receptors and SKF83566 (1μM)
to block D1-like receptors on cholinergic interneurons to pre-
vent changes in cholinergic tone in the striatum. The DA signal
was quantified by the area under the curve because the 2 pulse
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FIGURE 6 | Concentration-dependent multiple cocaine effects on the
DA-release signal evoked by 1 p stimulation in the striatum measured
by FCV. (A) In W-T mice DA signals were measured in the dorsolateral
striatum while we bath applied cocaine ranging from 50nM to 80μM in the
absence of GBR12909. At 50 nM to 1μM, cocaine monotonically increased
the amplitude and prolonged the duration of the evoked DA signal, as
expected from cocaine’s known inhibition of DATs (DAT effect). At cocaine
concentrations above 1μM, the DA peak decreased although the duration
was further prolonged. This decrease is hypothesized to arise from cocaine
inhibition of nAChRs (nAChR effect). (B) In β2-nAChR knockout (KO) mice in
the absence of GBR12909, the DA signal is not dependent on nAChRs.
Note that the mid-range cocaine inhibition of the DA amplitude is absent in
these measurements (i.e., the nAChR effect is absent). The difference
between cocaine’s influences in the absence of β2-nAChRs is shaded in
gray with the dotted curve representing the falling phase in (A). (A1,B1)
Examples of the multiple effects induced by different concentrations of
cocaine in WT and in β2-nAChR KO mice. (C) In W-T mice, DA signaling in
the NAc shell showed qualitatively similar cocaine effects as seen in the
dorsal striatum. (D) In β2-nAChR KO mice, the DA signal is not dependent
on nAChRs. The difference between cocaine’s influences in the absence of
β2-nAChRs is shaded in gray with the dotted curve representing the falling
phase in (C). In (A–D), n = 4–7 slices for each data points.
protocol spreads the DA signal in time. The paired-pulse ratio
(PPR) was defined as P2/P1. In the dorsolateral striatum of W-
T mice, DA release displayed strong paired-pulse depression with
a PPR of 0.12 ± 0.01, n = 7 (Figures 8A1,A3), consistent with
published reports (Rice and Cragg, 2004; Zhang and Sulzer,
2004; Zhang et al., 2009a; Cachope et al., 2012; Threlfell et al.,
2012). Although a high initial release probability is probably a
key factor, the mechanism for this severe depletion of DA release
is not established. In the presence of 10μM cocaine, the PPR
increased to 0.43 ± 0.06 (n = 5, p < 0.05; Figures 8A1–A3).
Qualitatively similar results were obtained in the NAc shell: PPR
was 0.47 ± 0.07, n = 5 in the control and 0.65 ± 0.08, n = 5 in
10μMcocaine (not shown). These PPR numbers reflect the lower
probability of release under control conditions in the NAc shell
compared to the dorsal striatum, which was shown previously
(Zhang et al., 2009a).
To examine further whether cocaine’s mechanism of action
on PPR was via nicotinic antagonism, we repeated the paired-
pulse experiment in nAChR β2 KO mice. In the absence of the
β2-containing nAChRs, the probability of release decreases espe-
cially for P1 (Zhou et al., 2001). Thus, in β2 KO mice with no
cocaine, the PPR was higher than in W-T mice, 0.38 ± 0.05,
(n = 5, Figures 8B1,B3). More importantly, in the absence of
functional β2-containing nAChRs, 10μM cocaine did not signifi-
cantly affect the PPR consistent with cocaine mechanistically act-
ing via nAChR inhibition: 0.39 ± 0.06 (n = 5, Figures 8B1–B3).
Qualitatively similar results were obtained in the NAc shell: PPR
was 0.68 ± 0.06 (n = 5) in the β2 KO mice and 0.65 ± 0.06
(n = 5) when cocaine (10μM) was applied (not shown). In the
absence of β2-containing nAChRs, cocaine did not influence
the PPR.
To further demonstrate that cocaine is altering the PPR via
nAChRs not owing to its inhibition of DATs, we repeated the
experiments in the presence of GBR12909 (5μM) to inhibit
DATs as a control for cocaine’s inhibition of DATs. Just as seen
in Figures 8A,B, cocaine caused an increase in the PPR when
nAChRs are present (Figures 8C1–C3) but not in β2 KO mice
(Figures 8D1–D3).
COCAINE ENHANCES PHASIC RELATIVE TO TONIC DA SIGNALS
DEPENDENT ON nAChRs
The earlier results showed that cocaine decreases DA release
evoked by a 1 p stimulus. A low release probability can be over-
come by the residual Ca2+ in axon terminals produced by high
frequency stimulation (Abbott and Regehr, 2004). Therefore, we
tested whether cocaine favors phasic DA release evoked by high
frequency stimulation.
Tonic DA release was evoked by 4 stimulation pulses given at
4Hz, and phasic DA release was mimicked by 4 pulses given at
20Hz because rodent DA neurons fire bursting spikes with an
intraburst frequency of ∼20Hz and with 3–5 spikes per burst,
and the averaged DA neuron firing rate is about 4Hz (Hyland
et al., 2002; Schultz, 2002; Zhang et al., 2009b). Under con-
trol conditions in the dorsolateral striatum, phasic and tonic DA
release was very similar (Rice and Cragg, 2004; Zhang and Sulzer,
2004; Zhang et al., 2009a), with the ratio of phasic to tonic DA
release being 1.10 ± 0.05, n = 10 (Figures 9A1,C). Inhibition of
DATs by GBR12909 (up to 5μM) did not affect the phasic to
tonic ratio (Figures 9A2,C). In contrast, 10μM cocaine reduced
the tonic DA release more strongly than the phasic DA signal
increasing the phasic to tonic DA ratio to 1.38 ± 0.15 (n = 8,
p < 0.05, Figures 9A3,C). To test whether cocaine was acting via
inhibition of nAChRs to influence the phasic to tonic ratio, we
repeated the experiment in nAChR β2 KO mice. Under control
conditions in β2 KOmice, the phasic to tonic DA release ratio was
1.58 ± 0.14 (n = 6, Figures 9B1,C), which is higher than in W-
T mice. Equally important, cocaine (up to 10μM) did not alter
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FIGURE 7 | Cocaine at high concentrations inhibits voltage-gated INa.
(A) In 40μM cocaine, INa was inhibited compared to the control or
after cocaine washout. Holding potential was −90mV and the testing
potential was 0mV for 10ms given every 20 s. Extracellular and
intracellular solutions are described in the Materials and Methods
section. (B) The dose-response curve for cocaine inhibition of INa is
shown on the right with a curve through the data with an IC50 = 144
and a Hill coefficient of 1.
FIGURE 8 | Cocaine reduces paired-pulse depression of DA release in
W-T but not in β2-nAChR KO mice. In this figure, P1 was the 1 stimulus
pulse-evoked DA signal shown in black and P2 (shown in blue) was obtained
by subtraction: the two paired pulses-evoked DA (red traces). (A,A1–A3) In
W-T mice under control conditions (without inhibition of DATs), paired-pulse
depression was strong, and the paired-pulse ratio (PPR, defined as P2/P1)
was small. In 10μM cocaine, the PPR significantly increased (n = 6). 1μM
sulpiride and SKF83566 were used in all these experiments to block local DA
receptor interactions within the dorsolateral striatum. (B,B1–B3) In β2-nAChR
KO mice (without inhibition of DATs), 10μM cocaine did not affect the PPR
(n = 5). (C,C1–C3) In W-T mice with DAT inhibition by GBR12909 (5μM)
cocaine (10μM) still enhances the PPR (n = 5). (D,D1–D3) In β2-nAChR KO
mice with inhibition of DATs, 10μM cocaine did not affect the PPR (n = 5).
∗p < 0.01.
the phasic to tonic DA ratio in β2 KO mice, 1.65 ± 0.17 (n = 6,
Figures 9B2,C). These data support the hypothesis that cocaine
acts via inhibition of nAChRs to increase the phasic to tonic DA
ratio.
DISCUSSION
The results from our present study indicate that at concentra-
tions achieved by cocaine abusers, cocaine inhibits nAChRs and
increases the ratio of phasic to tonic DA release. For example,
cocaine (10μM) decreased DA release evoked by a single, iso-
lated stimulation (1 p) by ∼70%, but that DA signaling loss
was partially recovered during a stimulus train (4 p at 20Hz).
Because this relative enhancement of phasic signaling is occurring
while cocaine also inhibits DA reuptake (i.e., inhibits DATs), the
phasic DA signals are larger during cocaine abuse. Salient, reward-
related DA signals arising from phasic DA neuron firing (Grace,
2000) will be highly exaggerated in cocaine concentrations greater
than about 2μM, which are easily achieved by cocaine abusers
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FIGURE 9 | Cocaine increased the phasic to tonic DA ratio in the dorsal
striatum of W-T and nAChR KO mice. Sulpiride and SKF83566 both at
1μM were used to block DA receptor interactions within the striatum.
(A,A1) The FCV measurements of DA signals evoked by lower frequency
tonic stimulation (4Hz, 4-pulses, left trace) and by phasic stimulation (20Hz,
4-pulses, right trace) under control conditions had a phasic to tonic DA
signal ratio close to 1. (A,A2) In 5μM GBR12909 to inhibit DATs selectively
(no cocaine), the DA signals evoked by tonic stimulation (left trace) and by
phasic stimulation (right trace) showed a phasic to tonic ratio near 1.
GBR12909 prolonged the DA signal duration but did not enhance the
phasic to tonic DA ratio. (A,A3) In 10μM cocaine, the DA signals evoked
by tonic stimulation (left trace) and phasic stimulation (right trace) showed a
larger phasic to tonic ratio. The DA signals were broader because cocaine
inhibited DATs and, thus, prolonged the DA signal duration. (B,B1) Cocaine
did not increase the phasic to tonic DA ratio in the dorsal striatum in
β2-nAChR KO Mice. The DA signal evoked by a tonic stimulation (4Hz,
4-pulses, left trace) and phasic stimulation (20Hz, 4-pulses, right trace)
under control conditions. In β2-nAChR KO mice the phasic to tonic DA
signal ratio was larger than 1 and larger than in W-T mice. (B,B2) In 10μM
cocaine, the DA signals evoked by a tonic stimulation (left trace) and by a
phasic stimulation (right trace) were prolonged, but the ratio of phasic to
tonic signal was unchanged compared to the no cocaine condition. Cocaine
did not dose-dependently enhance the phasic to tonic DA ratio in β2-nAChR
KO mice. Sulpiride and SKF83566 both at 1μM were used to block DA
receptor interactions within the striatum. (C) Summary graph showing the
PPR under different conditions. ∗p < 0.05, ∗∗p < 0.01.
(Mittleman and Wetli, 1984; Evans et al., 1996; Ward et al., 1997;
Fowler et al., 1998).
It must be kept in mind, however, that the striatal brain
slice preparation and the exogenous electrical stimulation of
the striatal tissue to evoke DA release is a reduced experi-
mental model system that allows us to examine the different
aspects of cocaine’s effect on the DA signal in the striatum.
As seen in Figure 6B, under these experimental conditions,
cocaine’s influence acting exclusively via nAChRs is mainly to
diminish the DA release that would be even larger owing to
cocaine’s inhibition of DATs. By inhibiting nAChRs, the stim-
ulus evoked DA release is not as large as would be achieved
if the nAChRs were not partially inhibited by cocaine (Zhang
et al., 2009a). In intact animals, cocaine’s effects are more com-
plex. For example, cocaine’s inhibition of DA uptake increases
the basal extracellular DA level that may activate the inhibitory
D2 autoreceptors that in turn reduce DA release (Schmitz
et al., 2002), complicating the determination of the physiological
functions of the individual receptors and neurotransmitter
systems.
NICOTINIC ANTAGONISM BY COCAINE REGULATES DA RELEASE IN
THE STRIATUM
The results from this study indicate three different cocaine con-
centration ranges that induce different antagonist actions (best
seen in Figure 6). At low concentrations, below 1μM (IC50 ∼=
0.5μM) (Ritz et al., 1987), cocaine inhibits DATs and elevates
extracellular DA by reducing DA reuptake. This is probably
cocaine’s most common effect in cocaine abusers for the sim-
ple reason that low cocaine concentrations are more common
and last longer than the high cocaine peak (Evans et al., 1996;
Ward et al., 1997; Fowler et al., 1998). At intermediate concen-
trations above 2μM (IC50 of 4.3μM), also commonly achieved
by cocaine abusers, cocaine begins to inhibit nAChRs (Figure 3B)
and, thereby, alters DA signaling via nicotinic mechanisms (Zhou
et al., 2001; Rice and Cragg, 2004; Zhang and Sulzer, 2004). At
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high concentrations above 10μM (IC50 ∼= 26.4μM) that can be
reached during a large cocaine dosing, local anesthetic-like effects
begin (Mittleman and Wetli, 1984; O’Leary and Chahine, 2002).
The mechanism for cocaine’s stronger inhibition of DA release
than that of voltage-gated Na current see in our data is not known;
we speculate that the Na current at the DA axon fibers and termi-
nals may be more sensitive to cocaine; the extensive DA axon fiber
bifurcations may also increase the sensitivity of the action poten-
tial generation and propagation to cocaine inhibition (Matsuda
et al., 2009; Debanne et al., 2011).
Our results show that in striatal slices fromW-T mice, cocaine
inhibited β2-containing nAChR-dependent DA release (from 1 p
stimulation) with an IC50 of 4.3μM (Figure 3B). In contrast, a
six time greater cocaine concentration is needed to depress 1 p-
stimulation DA release from β2-containing nAChR KOmice with
an IC50 of 26.4μM (Figure 5B). The data indicate that cocaine’s
inhibition of DA release is mediated by β2 nAChRs on DA fibers
and terminals that normally regulate DA release (Zhou et al.,
2001; Grady et al., 2002; Rice and Cragg, 2004; Salminen et al.,
2004; Zhang and Sulzer, 2004; Zhang et al., 2009a). This conclu-
sion is also supported by our finding that in DA neuron somata,
cocaine inhibited the β2∗ nAChR current (Figure 2B), consistent
with previous studies of cloned α4β2 nAChRs in expression sys-
tems (Damaj et al., 1999; Francis et al., 2000). The inhibition
of nAChR currents and DA release was quantitatively mimicked
by the selective nAChR antagonist DHβE (Figure 2B2). Because
cocaine often reaches greater than 2μM in the brains of abusers
(Mittleman and Wetli, 1984; Evans et al., 1996; Ward et al., 1997;
Fowler et al., 1998), our results indicate that biologically relevant
cocaine levels directly alter DA release.
The observation that weak cocaine inhibition of nAChRs
(Figure 2B) leads to a greatly amplified inhibition of DA release
(Figure 3A) likely arises from the site of nAChR action. nAChRs
on DA fibers and terminals regulate action potential propagation
and presynaptic calcium signals. For example, nAChRs medi-
ate direct and indirect Ca2+ elevation within axon terminals
(Vernino et al., 1992, 1994; Lena et al., 1993; McGehee et al.,
1995; Gray et al., 1996; Rathouz et al., 1996). Neurotransmitter
release is related to a high power (∼=4th) of intra-terminal Ca2+
(Zucker and Regehr, 2002; Lou et al., 2005). Consequently, even
a small decrease in the nAChR-initiated presynaptic Ca2+ sig-
nal or depolarization would induce a larger decrease in DA
release. This conclusion is supported by the quantitatively sim-
ilar data obtained with the specific nAChR inhibitor, DHβE,
which decreases nAChR-dependent DA release more strongly
than nAChR-mediated currents (Figures 2B, 3A).
A number of recent studies have shown that nAChR activity on
DA fibers and terminals regulates the relationship between affer-
ent action potentials and DA release. The nAChRs on DA fibers
and terminals increase the initial DA release probability, enhanc-
ing tonic DA signals (Grady et al., 2002; Rice and Cragg, 2004;
Salminen et al., 2004; Zhang and Sulzer, 2004; Exley and Cragg,
2008; Zhang et al., 2009a). nAChR activation may also directly
evoke action potentials in DA axon terminals and thus DA release
(Cachope et al., 2012; Threlfell et al., 2012). Inhibiting or desensi-
tizing striatal nAChRs decreases tonic DA release, but phasic DA
release arising from stimulus trains is not inhibited. This nicotinic
FIGURE 10 | Diagram showing that cocaine may inhibit DAT-mediated
DA uptake and DA release via nAChRs and Na channels in a
dose-dependent manner. Depol., depolarization.
effect increases the ratio of phasic to tonic DA release arising
from the biologically complex series of action potentials along DA
fibers (Rice and Cragg, 2004; Zhang and Sulzer, 2004; Zhang et al.,
2009a). By inhibiting nAChRs, cocaine influences this nicotinic
mechanism that alters the frequency dependence of DA release
favoring phasic signals.
BIOLOGICAL IMPLICATIONS
Our data indicate that besides inhibiting DAT, the most com-
mon effect on the DA system, cocaine, at concentrations (around
4μM) readily achievable in cocaine abusers (Evans et al., 1996;
Ward et al., 1997; Fowler et al., 1998), may also, via inhibit-
ing nAChRs, alter DA release property. On rare occasions
when the abuser uses very high doses of cocaine leading to a
cocaine level≥20μM, cocaine’s anesthetic effect may be triggered
(Figure 10). The functional importance of our data obtained
in brain slices is reflected in several behavioral studies show-
ing that nicotinic agonism increases the abusive potential of
cocaine whereas inhibition of nAChRs decreases cocaine rein-
forced behaviors (Reid et al., 1998; Zachariou et al., 2001;
Schoffelmeer et al., 2002; Blokhina et al., 2005; Champtiaux
et al., 2006; Zanetti et al., 2006). Particularly, pharmacological or
genetic inactivation of nAChRs before exposure to cocaine was
reported to disrupt place preference to cocaine, whereas low doses
of nicotine were able to lower the threshold for cocaine induced
place preference, and nAChR β2 KO mice showed decreased
cocaine induced place preference (Zachariou et al., 2001). It
was also reported that nAChR inhibition by mecamylamine dose
dependently suppressed cocaine self-administration (Blokhina
et al., 2005). These literature data clearly indicate that nAChRs are
involved in cocaine’s addictive processes, although the underlying
neural mechanisms are likely to be complex. Therefore, it is rea-
sonable to conclude that the mechanistic effects reported in this
study contribute to those in vivo findings: acting via inhibition of
nAChRs, cocaine increases the ratio of phasic to tonic DA release
and thus potentially enhances its reinforcing abilities (Goto and
Grace, 2005).
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